BETA-BLOCKERS AND CARDIOPROTECTION–IS THERE ANY GOOD NEWS FROM THE RECENT TRIALS?
Author:
- 1 December 1987
- journal article
- Published by Hindawi Limited in Journal of Clinical Pharmacy and Therapeutics
- Vol. 12 (6) , 347-350
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: A review of randomized controlled trialsProgress in Cardiovascular Diseases, 1986
- Cardiovascular Risk and Risk Factors in a Randomized Trial of Treatment Based on the Beta-Blocker Oxprenolol: The International Prospective Primary Prevention Study in Hypertension (IPPPSH)Journal Of Hypertension, 1985
- MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party.BMJ, 1985
- Long-term treatment with metoprolol after myocardial infarction: Effect on 3 year mortality and morbidityJACC, 1985
- Effects of propranolol on atherogenesis in the cholesterol-fed rabbit.Circulation Research, 1985
- Functional Bases for Individualities Among Vascular Smooth MusclesJournal of Cardiovascular Pharmacology, 1985
- Hemodynamic effects of antihypertensive drugs. Possible implications for the prevention of atherosclerosis.Hypertension, 1984
- The International Prospective Primary Prevention Study in Hypertension (IPPPSH): Objectives and methodsEuropean Journal of Clinical Pharmacology, 1984
- The influence of hypertension and other hemodynamic factors in atherogenesisProgress in Cardiovascular Diseases, 1983
- β-Blockers versus saluretics in hypertensionPreventive Medicine, 1981